Prognostic value of inflammatory markers alone and in combination with blood lipids in patients with stable coronary artery disease

European Journal of Internal Medicine

Volumn 16, Issue 1, 2005, Pages 47-52

  Hoffmeister, Albrecht ^a   Rothenbacher, Dietrich ^b   Kunze, Markus ^a   Brenner, Hermann ^b   Koenig, Wolfgang ^a,c  

^a UNIVERSITY OF ULM   (Germany)

^b GERMAN CENTRE FOR RESEARCH ON AGEING   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Biomarkers; Coronary disease; Inflammation; Prevention

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

EID: 14144249221     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2004.09.008     Document Type: Article

References (27)

1. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 1999 115 126
2. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
3. J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, and P. Appleby Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses BMJ 321 7255 2000 Jul. 22 199 204
4. A.R. Folsom, N. Aleksic, D. Catellier, H.S. Juneja, and K.K. Wu C-reactive protein and incident coronary heart disease in the ARIC study Am. Heart J. 144 2002 233 238
5. B.C. Berk, W.S. Weintraub, and R.W. Alexander Elevation of C-reactive protein in "active" coronary artery disease Am. J. Cardiol. 65 1990 168 172
6. B. Lindahl for the FRISC study group Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease N. Engl. J. Med. 343 2000 1139 1147
7. R.S. Rosenson, and W. Koenig High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease Curr. Opin. Cardiol. 17 2002 325 331
8. N. Rifai, and P.M. Ridker High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease Clin. Chem. 47 2001 403 411
9. M.F. McCarthy Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: downregulation with essential fatty acids, ethanol and pentoxifylline Med. Hypotheses 52 1999 465 477
10. P. Bogaty, P. Poirier, S. Simard, L. Boyer, S. Solymoss, and G.R. Dagenais Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina Circulation 103 2001 3062 3068
11. F. Haverkate for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group Production of C-reactive protein and risk of coronary events in stable and unstable angina Lancet 349 1997 462 466
12. C. Bickel, H.J. Rupprecht, S. Blankenberg, C. Espiniola-Klein, A. Schlitt, and G. Rippin Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease Am. J. Cardiol. 89 8 2002 Apr. 15 901 908
13. J.S. Zebrack for the intermountain heart collaboration study group C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina J. Am. Coll. Cardiol. 39 2002 632 637
14. L. Retterstol, L. Eikvar, M. Bohn, A. Bakken, J. Erikssen, and K. Berg C-reactive protein predicts death in patients with previous premature myocardial infarction-a 10 year follow-up study Atherosclerosis 160 2002 433 440
15. W.S. Speidl, S. Graf, S. Hornykewycz, M. Nikfardjam, A. Niessner, and G. Zorn High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease Am. Heart J. 144 3 2002 Sep. 449 455
16. F. Valente, M. Dramaix, D. De Bacquer, G. De Backer, and M. Kornitzer C-reactive protein predicts coronary mortality over ten years in a community-based study J. Am. Coll. Cardiol. 35 suppl. A 2000 304A [abstract]
17. A. Woods, D.J. Brull, S.E. Humphries, and H.E. Montgomery Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6 Eur. Heart J. 21 19 2000 Oct. 1574 1583
18. P.M. Ridker, N. Rifai, M.J. Stampfer, and C.H. Hennekens Plasma concentrations of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772
19. S. Valpato, J.M. Guralnik, L. Ferrucci, J. Balfour, P. Chaves, and L.P. Fried Related Articles, L Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study Circulation 103 7 2001 Feb. 20 947 953
20. T.B. Harris, L. Ferrucci, R.P. Tracy, M.C. Corti, S. Wacholder, and W.H. Ettinger Jr. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly Am. J. Med. 106 5 1999 May 506 512
21. I. Lemieux, B. Lamarche, C. Couillard, A. Pascot, B. Cantin, and J. Bergeron Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study Arch. Intern. Med. 161 22 2001 Dec 10-24 2685 2692
22. G. Walldius, I. Jungner, I. Holme, A.H. Aastveit, W. Kolar, and E. Steiner High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 2001 2026 2033
23. P.M. Ridker, R.J. Glynn, and C.H. Hennekens C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction Circulation 97 1998 2007 2011
24. G. Engström, P. Lind, B. Hedblad, L. Stavenow, L. Janzon, and F. Lindgärde Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men Circulation 105 2002 2632 2637
25. M.S. Sabatine, D.A. Morrow, J.A. de Lemos, C.M. Gibson, S.A. Murphy, and N. Rifai Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation 105 15 2002 Apr. 16 1760 1763
26. P.M. Ridker for the AFCAPS/TexCAPS investigators Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N. Engl. J. Med. 344 2001 1959 1965
27. D.L. Bhatt, and E.J. Topol Need to test the arterial inflammation hypothesis Circulation 106 2002 136 140